Company Filing History:
5 out of 1,650 
1 out of 1,829 
Years Active: 2005-2011
Title: The Innovations of Stephan Glaser
Introduction
Stephan Glaser is a notable inventor based in Seeshaupt, Germany. He has made significant contributions to the field of biochemistry, particularly in the production of recombinant trypsin. With a total of 5 patents, his work has advanced the understanding and application of enzymatic processes in medical science.
Latest Patents
Among his latest patents is the invention titled "Cleavage of precursors of insulins by a variant of trypsin." This invention focuses on producing a variant of recombinant trypsin that exhibits increased substrate specificity for arginine over lysine in non-animal host organisms. Additionally, it encompasses the use of recombinant porcine pancreatic trypsin variants for the cleavage of insulin precursors, along with kits containing the variant of trypsin. Another significant patent is "Method for producing recombinant trypsin," which details a method for producing recombinant trypsin from porcine pancreas that is soluble and secreted into the culture medium. This method effectively prevents the activation of trypsinogen and autolysis of trypsin, ensuring a more efficient production process.
Career Highlights
Stephan Glaser has worked with prominent companies in the pharmaceutical and diagnostics sectors. Notably, he has been associated with Roche Diagnostics Operations, Inc. and Sanofi-Aventis Deutschland GmbH. His experience in these organizations has contributed to his expertise in enzymatic research and development.
Collaborations
Throughout his career, Stephan has collaborated with esteemed colleagues, including Frank Geipel and Johann-Peter Thalhofer. These partnerships have fostered innovation and have been instrumental in advancing his research endeavors.
Conclusion
Stephan Glaser's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the production of important medical enzymes, showcasing the impact of innovation in science.